Guggenheim Capital’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,172
Closed -$648K 1852
2023
Q2
$648K Sell
22,172
-1,000
-4% -$27.4K 0.01% 1345
2023
Q1
$651K Buy
23,172
+3,764
+19% +$96.6K 0.01% 1374
2022
Q4
$360K Sell
19,408
-2,588
-12% -$44.3K ﹤0.01% 1615
2022
Q3
$346K Sell
21,996
-328
-1% -$7.37K ﹤0.01% 1618
2022
Q2
$563K Sell
22,324
-499
-2% -$14.9K ﹤0.01% 1525
2022
Q1
$824K Buy
22,823
+3,962
+21% +$195K 0.01% 1456
2021
Q4
$1.45M Buy
18,861
+4,791
+34% +$422K 0.01% 1212
2021
Q3
$1.35M Buy
+14,070
New +$1.54M 0.01% 1262

Other funds holding CRNC

Guggenheim Capital's CRNC Position: Q3 2023 in Review

Guggenheim Capital sold out of Cerence (CRNC) in Q3 2023, closing a stake of 22,172 shares — an estimated $648K sold.

Guggenheim Capital first reported a position in CRNC in Q3 2021 and held it in 8 quarters. The position peaked at $1.45M in Q4 2021. 216 funds tracked by Wall St. Rank hold CRNC as of Q3 2023.

  • Guggenheim Capital reported no remaining Cerence position as of Q3 2023 after selling out during the quarter.
  • Guggenheim Capital sold 22,172 Cerence shares in Q3 2023, an estimated $648K.
  • Guggenheim Capital first reported a position in Cerence in Q3 2021 and held it in 8 quarters.
  • Guggenheim Capital's Cerence position peaked at $1.45M in Q4 2021.
  • 216 funds tracked by Wall St. Rank held Cerence as of Q3 2023.

Based on Guggenheim Capital's 13F filing for Q3 2023, filed 14 Nov 2023.